Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

1.3K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.3K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

1.8K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
1.8K
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

2.5K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
2.5K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

2.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
2.6K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

394
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
394
Detailed Structure and Function of Lymph Nodes01:23

Detailed Structure and Function of Lymph Nodes

2.1K
Lymph nodes are bean-shaped structures that cluster along the lymphatic vessels in the inguinal, axillary, and cervical regions. Each node is divided into compartments by a capsule that extends trabeculae inward.
From a histological perspective, lymph nodes can be split into two main areas: the superficial cortex and the deep medulla. The outer cortex is populated by dendritic cells, macrophages, and B lymphocytes, which are densely packed into follicles. When these B-lymphocytes are presented...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recommendations from German and international guidelines on long-term survivorship care after cancer: A scoping review and evidence maps.

Critical reviews in oncology/hematology·2026
Same author

Feasibility and safety of rapid glofitamab ramp-up.

Leukemia·2026
Same author

Response-adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohort.

British journal of haematology·2026
Same author

Health-related quality of life after autologous stem cell transplantation for multiple myeloma or lymphoma impacts professional activity- an analysis from two German tertiary care centers.

Frontiers in oncology·2026
Same author

Pathogenesis of diffuse large B cell lymphoma proteogenotypes.

Cancer cell·2026
Same author

Epcoritamab in Richter Transformation: Insights from a Real-World Case Series.

Blood advances·2026

Related Experiment Video

Updated: Aug 6, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.3K

Diffuse Large B-Cell Lymphoma and Related Entities.

Moritz Ernst1, Ulrich Dührsen, Dirk Hellwig

  • 1Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne; Clinic for Hematology, University Hospital Essen; Department for Nuclear Medicine, University Hospital Regensburg; Department of Medicine A for Hematology, Oncology, and Pneumology, University Hospital Münster.

Deutsches Arzteblatt International
|March 21, 2023
PubMed
Summary

This guideline provides evidence-based recommendations for diffuse large B-cell lymphoma (DLBCL) treatment. It emphasizes R-CHOP immunochemotherapy, PET/CT staging, and consolidative radiotherapy for residual disease in DLBCL management.

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.2K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.2K

Related Experiment Videos

Last Updated: Aug 6, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.3K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.2K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.2K

Area of Science:

  • Hematology
  • Oncology
  • Clinical Practice Guidelines

Background:

  • Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin's lymphoma.
  • DLBCL affects approximately 5.6 per 100,000 individuals annually, typically around age 65.
  • No prior evidence-based guidelines existed for DLBCL management.

Purpose of the Study:

  • To establish the first international evidence-based guideline for DLBCL diagnosis, treatment, and follow-up.
  • To standardize clinical management and identify areas for improvement in DLBCL care.
  • To provide a foundation for future research in DLBCL.

Main Methods:

  • Conducted systematic literature searches, including 5 systematic reviews and 21 randomized controlled trials (RCTs).
  • Formulated 42 recommendations based on evidence and 142 based on expert consensus.
  • Utilized a structured consensus-finding process for recommendation approval.

Main Results:

  • Recommends combined PET/CT for DLBCL staging.
  • Advocates R-CHOP immunochemotherapy for newly diagnosed DLBCL patients without contraindications.
  • Suggests PET/CT post-treatment to assess remission and consolidative radiotherapy for PET-positive residual disease.

Conclusions:

  • This guideline offers a standardized approach to DLBCL management.
  • It addresses diagnosis, treatment, and follow-up for DLBCL patients.
  • The guideline serves as a basis for future DLBCL research and clinical practice improvements.